Ethics of randomised controlled trials - Not yet time to give up on equipoise

Arthritis Research and Therapy

Volumn 6, Issue 6, 2004, Pages 237-239

  Ashcroft, Richard E ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Design bias; Ethical principles; Expected outcomes; Randomised controlled trials

Indexed keywords

BOLDENONE UNDECENOATE; PLACEBO;

ARTICLE; BAYES THEOREM; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; MEDICAL DECISION MAKING; QUALITATIVE ANALYSIS; QUALITY OF LIFE; RESEARCH ETHICS; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

BAYES THEOREM; BIAS (EPIDEMIOLOGY); BIOLOGICAL MARKERS; CLINICAL TRIALS, PHASE III; CULTURE; HUMANS; MORAL OBLIGATIONS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 8544232788     PISSN: 14786354     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar1442     Document Type: Article

References (21)

1. Fries JF, Krishnan E: Equipoise, design bias, and randomised controlled trials: the elusive ethics of new drug development. Arthritis Res Ther 2004, 6:R250-R255.
2. Fried C: Medical Experimentation: Personal Integrity and Social Policy. Amsterdam: North Holland; 1974.
3. Freedman B: Equipoise and the ethics of clinical research. New Engl J Med 1987, 317:141-145.
4. Miller PB, Weijer C: Rehabilitating equipoise. Kennedy Inst Ethics J 2003, 13:93-118.
5. Veatch R: Indifference of subjects; an alternative to equipoise in randomised clinical trials. In Bioethics. Edited by Paul EF, Miller FD, Paul J. Cambridge: Cambridge University Press; 2002: 295-323.
6. Gifford F: Freedman's 'clinical equipoise' and 'sliding-scale all-dimensions-considered' equipoise. J Med Philos 2000, 25: 399-426.
7. Ashcroft RE: Equipoise, knowledge and ethics in clinical research and practice. Bioethics 2000, 13:314-326.
8. Ashcroft RE: Giving medicine a fair trial [editorial]. BMJ 2000, 320:1686.
9. Urbach P: The value of randomisation and control in clinical trials. Stat Med 1993, 12:1421-1441.
10. Worrall J: What evidence in evidence-based medicine? Philos Sci 2002, 69:S316-S330.
11. Kadane JB (Ed): Bayesian Methods and Ethics in Clinical Trial Design. Chichester: John Wiley; 1996.
12. Spiegelhalter DJ, Myles JP, Jones DR, Abrams KR: Bayesian methods in health technology assessment: a review. Health Technol Assess 2000, 4(38):1-121.
13. Djulbegovic B, Hozo I: At what degree of belief in a research hypothesis is a trial in humans justified? J Eval Clin Pract 2002, 8:269-276.
14. Ashby D, Smith AFM: Evidence-based medicine as Bayesian decision-making. Stat Med 2000, 19:3291-3305.
15. Lilford RJ: Ethics of clinical trials from a bayesian and decision analytic perspective: whose equipoise is it anyway? BMJ 2003, 326:980-981.
16. Chard JA, Lilford RJ: The use of equipoise in clinical trials. Soc Sci Med 1998, 47:891-898.
17. Djulbegovic B, Lacevic M, Cantor A, Fields KK, Bennett CL, Adams JR, Kuderer NM, Lyman GH: The uncertainty principle and industry-sponsored research. Lancet 2000, 356:635-638.
18. Dieppe P: Evidence-based medicine or medicines-based evidence? Ann Rheum Dis 1998, 57:385-386.
19. Tallon D, Chard J, Dieppe P: Relation between agendas of the research community and the research consumer. Lancet 2000, 355:2037-2040.
20. World Medical Association: Declaration of Helsinki. Revision of 2000 with note of clarification, 2002 [http://www.wma.net/e/ policy/b3.htm]
21. Schüklenk U: Access to Experimental Drugs in Terminal Illness. New York: Pharmaceutical Products Press; 1997.